Skip to main content

Celgene Corporation



) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.6%. By the end of trading, Celgene Corporation rose $2.21 (3.4%) to $67.49 on average volume. Throughout the day, 5.2 million shares of Celgene Corporation exchanged hands as compared to its average daily volume of 3.7 million shares. The stock ranged in a price between $65.53-$68.80 after having opened the day at $67.48 as compared to the previous trading day's close of $65.28. Other companies within the Health Care sector that increased today were:




), up 23.7%,

Spectranetics Corporation



), up 18%,




), up 13.2%, and

Synta Pharmaceuticals



), up 12.2%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes various therapies to treat cancer and immune-inflammatory related diseases primarily in the United States and Europe. Celgene Corporation has a market cap of $28.19 billion and is part of the


industry. The company has a P/E ratio of 19.9, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are down 3.4% year to date as of the close of trading on Wednesday. Currently there are 22 analysts that rate Celgene Corporation a buy, no analysts rate it a sell, and three rate it a hold.

TheStreet Ratings rates Celgene Corporation as a


. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front,

Aoxing Pharmaceutical Company



), down 21.2%,

Hill-Rom Holdings



), down 18.1%,




), down 13.2%, and

China Pharma



), down 11.8%, were all laggards within the health care sector with

Varian Medical Systems



) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care